Their data suggested that the inhibition of MEK leads to differential intracellular stress response in different NB subtypes and the most resistant cell lines generated unique patterns in protein profiling indicating the utility of these proteins as biomarkers for therapeutic response. This evidence concerns the gene MAP2K7 and neuroblastoma.